Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
The Pharmaceutical Market: Serbia
Management Report
Published: January 2010
Pages: 20
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00 Buy Now!
Research from: Espicom
Sector: Prescription Medicines
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
The Republic of Serbia is located in the south of Central Europe and has two ‘autonomous’ provinces, Vojvodina in the north and Kosovo in the south. Kosovo declared its independence from Serbia in February 2008. Many EU members supported this move, but Serbia refuses to do so. Serbia became separate from Montenegro in June 2006. The population in 2010 stands at an estimated 7.3 million.
The health system in Serbia is funded primarily by the Republican Health Insurance Fund (HIF). In theory, the insurance scheme provides universal coverage and reimburses a wide range of services. The generous packages in additional to non-payments by farmers and the self-employed have led to financial difficulties in the fund, however. The government is considering raising out-of-pocket expenditure to reduce the deficit.
Germany and Switzerland accounted for around 21% of imports in 2006. The EU supplied 48.0% of imports in the same year. The value of imports has risen consistently in recent years, with an increase of 37.5% in 2006.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care dat
The health system in Serbia is funded primarily by the Republican Health Insurance Fund (HIF). In theory, the insurance scheme provides universal coverage and reimburses a wide range of services. The generous packages in additional to non-payments by farmers and the self-employed have led to financial difficulties in the fund, however. The government is considering raising out-of-pocket expenditure to reduce the deficit.
Germany and Switzerland accounted for around 21% of imports in 2006. The EU supplied 48.0% of imports in the same year. The value of imports has risen consistently in recent years, with an increase of 37.5% in 2006.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care dat